A detailed history of Verition Fund Management LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 12,500 shares of CDXS stock, worth $40,125. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,500
Holding current value
$40,125
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.65 - $3.92 $33,125 - $49,000
12,500 New
12,500 $38,000
Q3 2022

Nov 14, 2022

BUY
$6.06 - $12.86 $96,414 - $204,602
15,910 New
15,910 $96,000
Q1 2022

May 13, 2022

SELL
$16.97 - $31.93 $149,437 - $281,175
-8,806 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$25.61 - $41.78 $225,521 - $367,914
8,806 New
8,806 $275,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $210M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.